Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kersten

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The Annals of Thoracic Surgery|June 26, 2003
Replacement of the aortic valve in patients under 50 years of age: long-term follow-up of the St. Jude Medical prosthesisRobert W Emery, Carla A Erickson, Kit V Arom, et al.
Rheumatology (Oxford, England)|February 11, 2020
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosisBrigit E Kersten, Nathan den Broeder, Frank H J van den Hoogen, et al.
The Journal of Heart Valve Disease|February 15, 2002
Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesisRobert W Emery, Kit V Arom, Vibhu R Kshettry, et al.
Rheumatology (Oxford, England)|October 20, 2019
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosisBrigit E Kersten, Nathan den Broeder, Frank H J van den Hoogen, et al.
The Heart Surgery Forum|January 23, 2002
The initial United States experience with the ATS mechanical cardiac valve prosthesisR W Emery, R J Petersen, T E Kersten, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 25, 2019
In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical developmentP Zane, H Gieschen, E Kersten, et al.
The Journal of Heart Transplantation|May 1, 1986
Use of the mini Jarvik-7 total artificial heart as a bridge to transplantationL D Joyce, M R Pritzker, J C Kiser, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 1989
Mechanical circulatory support as a bridge to transplantationL D Joyce, R W Emery, F Eales, et al.
Trials|August 24, 2018
Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trialWieneke M T van den Hombergh, Brigit E Kersten, Hanneke K A Knaapen-Hans, et al.
Autoimmunity|April 5, 2021
Autoantibody profiles in systemic sclerosis; a comparison of diagnostic testsWynand Alkema, Hans Koenen, Brigit E Kersten, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Annals of Thoracic Surgery|June 26, 2003
Replacement of the aortic valve in patients under 50 years of age: long-term follow-up of the St. Jude Medical prosthesisRobert W Emery, Carla A Erickson, Kit V Arom, et al.
Rheumatology (Oxford, England)|February 11, 2020
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosisBrigit E Kersten, Nathan den Broeder, Frank H J van den Hoogen, et al.
The Journal of Heart Valve Disease|February 15, 2002
Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesisRobert W Emery, Kit V Arom, Vibhu R Kshettry, et al.
Rheumatology (Oxford, England)|October 20, 2019
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosisBrigit E Kersten, Nathan den Broeder, Frank H J van den Hoogen, et al.
The Heart Surgery Forum|January 23, 2002
The initial United States experience with the ATS mechanical cardiac valve prosthesisR W Emery, R J Petersen, T E Kersten, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 25, 2019
In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical developmentP Zane, H Gieschen, E Kersten, et al.
The Journal of Heart Transplantation|May 1, 1986
Use of the mini Jarvik-7 total artificial heart as a bridge to transplantationL D Joyce, M R Pritzker, J C Kiser, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 1989
Mechanical circulatory support as a bridge to transplantationL D Joyce, R W Emery, F Eales, et al.
Trials|August 24, 2018
Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trialWieneke M T van den Hombergh, Brigit E Kersten, Hanneke K A Knaapen-Hans, et al.
Autoimmunity|April 5, 2021
Autoantibody profiles in systemic sclerosis; a comparison of diagnostic testsWynand Alkema, Hans Koenen, Brigit E Kersten, et al.
Pageof 7